Literature DB >> 33067322

AMPKβ1 and AMPKβ2 define an isoform-specific gene signature in human pluripotent stem cells, differentially mediating cardiac lineage specification.

Nicole Ziegler1, Erik Bader1, Alexey Epanchintsev1, Daniel Margerie1, Aimo Kannt1, Dieter Schmoll2.   

Abstract

AMP-activated protein kinase (AMPK) is a key regulator of energy metabolism that phosphorylates a wide range of proteins in order to maintain cellular homeostasis. AMPK consists of three subunits: α, β and γ. AMPKα and β are encoded by two genes, the γ subunit by three genes, all of which being expressed in a tissue-specific manner. If individual isoforms have different functions is not understood so far. Using RNA-Seq technology, we provide evidence that the loss of AMPKβ1 and AMPKβ2 lead to different gene expression profiles in human induced pluripotent stem cells (hiPSCs), indicating isoform-specific function. The knockout of AMPKβ2 was associated with a higher number of differentially regulated genes than the deletion of AMPKβ1, suggesting that AMPKβ2 has a more comprehensive impact on the transcriptome. Bioinformatics analysis identified cell differentiation as one biological function being specifically associated with AMPKβ2. Correspondingly, the two isoforms differentially affected lineage decision towards a cardiac cell fate. While the lack of PRKAB1 impacted differentiation into cardiomyocytes only at late stages of cardiac maturation, the availability of PRKAB2 was indispensable for mesoderm specification as shown by gene expression analysis and histochemical staining for cardiac lineage markers such as cTnT, GATA4, and NKX2.5. Ultimately, the lack of AMPKβ1 impairs, while deficiency of AMPKβ2 abrogates differentiation into cardiomyocytes. Finally, we demonstrate that AMPK affects cellular physiology by engaging in the regulation of hiPSC transcription in an isoform-specific manner, providing the basis for further investigations elucidating the role of dedicated AMPK subunits in the modulation of gene expression. Published under license by The American Society for Biochemistry and Molecular Biology, Inc.

Keywords:  AMP-activated kinase (AMPK); cardiac development; cardiomyocyte; cell differentiation; energy metabolism; gene expression; induced pluripotent stem cell (iPS cell) (iPSC); isoforms; lineage decision; mesoderm

Year:  2020        PMID: 33067322     DOI: 10.1074/jbc.RA120.013990

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization.

Authors:  S M Warden; C Richardson; J O'Donnell; D Stapleton; B E Kemp; L A Witters
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

Review 2.  AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance.

Authors:  Daniel Garcia; Reuben J Shaw
Journal:  Mol Cell       Date:  2017-06-15       Impact factor: 17.970

3.  Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.

Authors:  Emily C Cokorinos; Jake Delmore; Allan R Reyes; Bina Albuquerque; Rasmus Kjøbsted; Nicolas O Jørgensen; Jean-Luc Tran; Aditi Jatkar; Katherine Cialdea; Ryan M Esquejo; John Meissen; Matthew F Calabrese; Jason Cordes; Robert Moccia; David Tess; Christopher T Salatto; Timothy M Coskran; Alan C Opsahl; Declan Flynn; Matthew Blatnik; Wenlin Li; Erick Kindt; Marc Foretz; Benoit Viollet; Jessica Ward; Ravi G Kurumbail; Amit S Kalgutkar; Jørgen F P Wojtaszewski; Kimberly O Cameron; Russell A Miller
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

4.  Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity.

Authors:  Gregory R Steinberg; Hayley M O'Neill; Nicolas L Dzamko; Sandra Galic; Tim Naim; René Koopman; Sebastian B Jørgensen; Jane Honeyman; Kimberly Hewitt; Zhi-Ping Chen; Jonathan D Schertzer; John W Scott; Frank Koentgen; Gordon S Lynch; Matthew J Watt; Bryce J W van Denderen; Duncan J Campbell; Bruce E Kemp
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

5.  AMP-activated protein kinase phosphorylates transcription factors of the CREB family.

Authors:  D M Thomson; S T Herway; N Fillmore; H Kim; J D Brown; J R Barrow; W W Winder
Journal:  J Appl Physiol (1985)       Date:  2007-12-06

6.  Transcriptome-guided functional analyses reveal novel biological properties and regulatory hierarchy of human embryonic stem cell-derived ventricular cardiomyocytes crucial for maturation.

Authors:  Ellen Poon; Bin Yan; Shaohong Zhang; Stephanie Rushing; Wendy Keung; Lihuan Ren; Deborah K Lieu; Lin Geng; Chi-Wing Kong; Jiaxian Wang; Hau San Wong; Kenneth R Boheler; Ronald A Li
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

7.  Involment of RAS/ERK1/2 signaling and MEF2C in miR-155-3p inhibition-triggered cardiomyocyte differentiation of embryonic stem cell.

Authors:  Xiang Ling; Dongbo Yao; Lumei Kang; Jing Zhou; Ying Zhou; Hui Dong; Keping Zhang; Lei Zhang; Hongping Chen
Journal:  Oncotarget       Date:  2017-09-23

8.  O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.

Authors:  Wei-Zhong Zhu; Danny El-Nachef; Xiulan Yang; Dolena Ledee; Aaron K Olson
Journal:  J Am Heart Assoc       Date:  2019-06-04       Impact factor: 5.501

9.  Hsa-miR-335 regulates cardiac mesoderm and progenitor cell differentiation.

Authors:  Maryam Kay; Bahram Mohammad Soltani; Fahimeh Hosseini Aghdaei; Hassan Ansari; Hossein Baharvand
Journal:  Stem Cell Res Ther       Date:  2019-06-27       Impact factor: 6.832

10.  YAP repression of the WNT3 gene controls hESC differentiation along the cardiac mesoderm lineage.

Authors:  Conchi Estarás; Hui-Ting Hsu; Ling Huang; Katherine A Jones
Journal:  Genes Dev       Date:  2017-12-21       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.